You have not verified your Email yet. Please verify your Email to create alerts
Verify Email
BH.IMMUN&BIO
|
Bharat Immunological
|
Abbott India
|
Panacea Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-29.83 % | 26.29 % | 19.34 % |
|
5yr average Equity Multiplier
|
3.08 | 1.46 | 2.01 |
|
5yr Average Asset Turnover Ratio
|
0.61 | 1.18 | 0.39 |
|
5yr Avg Net Profit Margin
|
-18.38 % | 15.35 % | 20.95 % |
|
Price to Book
|
1.66 | 17.81 | 0.99 |
|
P/E
|
0.0 | 48.33 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
206.63 Days | -44.73 Days | -83.17 Days |
|
Inventory Days
|
125.06 Days | 51.2 Days | 118.8 Days |
|
Days Receivable
|
61.4 Days | 20.12 Days | 54.62 Days |
|
Days Payable
|
117.81 Days | 107.05 Days | 284.35 Days |
|
5yr Average Interest Coverage Ratio
|
-2.32 | 119.35 | 2.91 |
|
5yr Avg ROCE
|
-44.64 % | 34.73 % | -10.17 % |
|
5yr Avg Operating Profit Margin
|
-16.19 % | 22.64 % | -2.87 % |
|
5 yr average Debt to Equity
|
0.71 | 0.0 | 0.41 |
|
5yr CAGR Net Profit
|
23.51 % | 16.09 % | n/a |
|
5yr Average Return on Assets
|
-10.1 % | 18.03 % | 7.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.25 % | 74.99 % | 73.59 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 4.35 % | -1.27 % |
|
Bharat Immunological
|
Abbott India
|
Panacea Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|
